GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 209 filers reported holding GENMAB A/S in Q1 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $455,935 | -9.1% | 12,927 | -2.0% | 0.02% | -15.8% |
| Q2 2023 | $501,352 | -3.8% | 13,190 | -4.5% | 0.02% | -9.5% |
| Q1 2023 | $521,390 | -23.8% | 13,808 | -14.5% | 0.02% | -43.2% |
| Q4 2022 | $684,479 | +70.3% | 16,151 | +29.2% | 0.04% | +37.0% |
| Q3 2022 | $402,000 | +28.0% | 12,502 | +29.3% | 0.03% | +22.7% |
| Q2 2022 | $314,000 | -28.3% | 9,669 | -20.1% | 0.02% | -26.7% |
| Q1 2022 | $438,000 | +27.0% | 12,103 | +38.7% | 0.03% | +11.1% |
| Q4 2021 | $345,000 | -8.2% | 8,724 | +1.4% | 0.03% | -28.9% |
| Q3 2021 | $376,000 | +35.7% | 8,602 | +26.8% | 0.04% | +11.8% |
| Q2 2021 | $277,000 | – | 6,786 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |